Aminoglycoside monitoring in neonates--a re-appraisal.
D000583:Amikacin / Q000009:adverse effects / Q000097:blood; D000617:Aminoglycosides / Q000009:adverse effects / Q000097:blood* / Q000627:therapeutic use; D005839:Gentamicins / Q000009:adverse effects / Q000097:blood; D006801:Humans; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000139:chemically induced; D007759:Labyrinth Diseases / Q000139:chemically induced; D008991:Monitoring, Physiologic
D000617:Aminoglycosides; D005839:Gentamicins; D000583:Amikacin